PARP1 and glioblastoma: A novel radioactive binding assay using [3H]WC-DZ in a PARP-1 high expression glioblastoma cell line was validated and set up for in vitro measurement of PARP-1 in cancer tissues or cell lines and for high throughput screening of next-generation PARP-1 inhibitors.